Follow The Filings

TVTX position history

The shares of Travere Therapeutics (TVTX) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q2: 34,315 shares, $1.9M, 0.02% of portfolio, New
  2. 2026 Q3: 52,988 shares, $3.1M, 0.03% of portfolio, Add +54.4%
Holdings date Value % of holdings Shares Filing date All 13F holders